Mp. Merker et Ca. Dawson, CYCLOPHILIN-FACILITATED BRADYKININ INACTIVATION IN THE PERFUSED RAT LUNG, Biochemical pharmacology, 50(12), 1995, pp. 2085-2091
Cis and trans isomers of X-proline (X-Pro) bonds can influence some as
pects of the kinetics of peptide metabolism. We previously used the pe
ptidyl-prolyl cis-trans isomerase, cyclophilin, to show that angiotens
in converting enzyme (ACE) preferentially hydrolyzes the trans isomer
of a synthetic tripeptide that contains a C-terminal proline (Dawson e
t at, Am J Physiol 257: H853-H865, 1989; Merker et at, J Appl Physiol
75: 1519-1524 1993). Bradykinin (Arg-Pro-Pro-Gly-Phe Ser-Pro-Phe-Arg)
exists as both cis and trans isomers at all three X-Pro bonds, and alt
hough its inactivation in the lung by pulmonary endothelial peptidases
is extensive, commonly a small fraction of the peptide survives passa
ge through the lung. To determine whether the presence of cis X-Pro bo
nds might limit the extent of bradykinin metabolism in the lung, we st
udied inactivation of bradykinin by the isolated perfused rat lung usi
ng the rabbit jugular vein superfused with the pulmonary venous efflue
nt as a bioassay for bradykinin. A large fraction (>90%) of the bradyk
inin in a bolus injection was inactivated in a single transit through
the pulmonary circulation, but a detectable fraction emerged in the ve
nous effluent. The addition of cyclophilin to the bradykinin in the bo
lus reduced the bradykinin emerging from the lungs to virtually undete
ctable levels. When the isomerase inhibitor cyclosporin A was included
with bradykinin and cyclophilin in the injectate, this effect of cycl
ophilin was reversed. These observations suggest that the fraction of
bradykinin that normally survives passage through the lungs contains i
somers that have at least one X-Pro bond that is refractory to enzymat
ic inactivation and whose isomerization time constant is significantly
longer than the pulmonary capillary transit time.